Background: Condylomata acuminata (CA) are caused by human papillomavirus. Most conventional therapies for CA have high recurrence rate. Objectives: To compare the recurrence rate of 5-aminolaevulinic acid photodynamic therapy (ALA-PDT) combined with CO2 laser and CO2 laser alone for CA treatment in mainland China. Methods: In this meta-analysis, 2,048 cases of CA from 22 articles were divided into two groups. The treatment group was treated by using ALA-PDT combined with CO2 laser, and CO2 laser alone was applied in the control group. The recurrence rate of the two groups was calculated and compared. Results: The recurrence rate was 42.67% (451/1,057) in the control group and 10.29% (102/991) in the treatment group, with a significant statistical difference between the two groups (χ2 = 271.98, p < 0.0001). Conclusion: ALA-PDT combined with CO2 laser was more effective in decreasing the recurrence rate of CA compared with CO2 laser alone. It might offer a wide clinical application for CA treatment.

1.
Stockfleth E, Meyer T: The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts. Expert Opin Biol Ther 2012;12:783-793.
2.
Stanley MA: Genital human papillomavirus infections: current and prospective therapies. J Gen Virol 2012;93:681-691.
3.
Gissmann L, deVilliers EM, zur Hausen H: Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer 1982;29:143-146.
4.
Grayson W: Infectious diseases of the skin; in Calonje E, Brenn T, Lazar A, McKee P (eds): McKee's Skin Pathology with Clinical Correlations, ed 4. Toronto, Elsevier, 2012, pp 760-895.
5.
Larikov D, Duke W, Skiest D: Extensive development of flat warts as a cutaneous manifestation of immune reconstitution syndrome. AIDS Read 2008;18:524-527.
6.
Langley PC, White DJ, Drake SM: The costs of treating external genital warts in England and Wales: a treatment pattern analysis. Int J STD AIDS 2004;15:501-508.
7.
Wroński K, Bocian R: Surgical excision of extensive anal condylomata is a safe operation without risk of anal stenosis. Postepy Hig Med Dosw (Online) 2012;66:153-157.
8.
Lacey CJ, Goodall RL, Tennval GR, et al: Randomized controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003;79:270-275.
9.
Kim YW, Bae SM, Battogtokh G, et al: Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells: in vivo and in vitro studies. PLoS One 2012;7:e38583.
10.
Li H, Min Z, Shan M, et al: Clinical observation on ALA-PDT combined with carbon dioxide laser therapy in the treatment of condyloma acuminatum. Chin J Dermatol Venereol 2009;23:364-365.
11.
Liu Z, Lei L, Tang Z, et al: Clinical observation on the recurrence rate of 5-aminolevulinic acid-photodynamic and CO2 laser therapy in the treatment of condyloma acuminatum. Chin J Dermatol Venereol Integ Trad W Med 2011;10:31-32.
12.
Wang H, Wang X, Guo M, et al: 5-aminolevulinic acid-photodynamic therapy and CO2 laser therapy for condyloma acuminatum. J Clin Dermatol 2006;35:674-675.
13.
Chen L, Deng J: Recurrence prevention of condylomata acuminata using ALA-PDT therapy. Chin J Dermatol Venereol 2009;23:500-501.
14.
Shi H, Yang J, Duan A, et al: Preventive effect of photodynamic therapy with topical application of 5-aminolevulinic acid on condyloma acuminatum recurrence. J Ningxia Med Univ 2011;33:646-648.
15.
Ge W, Wang Y, Li Y, et al: Observation of the efficacy of ALA-PDT on 65 patients with recurrent condylomata acuminata. Chin J Dermatol Venereol 2009;23:99-100.
16.
Wang A, Zhang H, Li W, et al: 5-aminolevulinic acid-photodynamic therapy on 30 condyloma acuminatum cases. China Trop Med 2010;10:329-330.
17.
Zhong W, Mo H, Li W, et al: Clinical observation on 5-aminolevulinic acid-photodynamic and CO2 laser therapy in the treatment of condyloma acuminatum. J Diagn Ther Dermatol Venereol 2011;18:184-185.
18.
Yang G, Yin L, Mei L: A clinical control study on ALA-PDT combined with CO2 laser therapy in the treatment of condyloma acuminatum. Chin J Dermatol Venereol 2010;24:643-644.
19.
Xu B, Zhu Y, He X, et al: Clinical study of 5-aminolevulinic acid-photodynamic therapy for condyloma acuminatum. Pract Clin Med 2009;10:52-59.
20.
Lv P: Clinical observation on 5-aminolevulinic acid-photodynamic and CO2 laser for the treatment of condyloma acuminatum. Contemp Med 2010;16:217.
21.
Huang Y, Zheng X, Lan L, et al: Efficacy of 5-aminolevulinic acid photodynamic therapy for genital warts. Hainan Med J 2011;22:30-32.
22.
Chen X, Wang Y, Lin S, et al: Clinical observation on 5-aminolevulinic acid-photodynamic and CO2 laser therapy in the treatment of condyloma acuminatum. South China J Dermatol Venereol 2009;16:262-264.
23.
Chen Q, Fu W, Zhang Q, et al: Effect of ALA-PDT on condyloma acuminatum. Chin J Dermatol Venereol 2011;25:325-327.
24.
Hu J, Zhao H: Observation of the efficacy of ALA-PDT on 52 patients with condylomata acuminata. J North China Coal Med Univ 2010;12:74-75.
25.
Li D, Sun D, Jiang H, et al: Observation of the efficacy of ALA-PDT for the treatment of condylomata acuminata. Chin Community Doct 2011;13:76.
26.
Wang J, Ji P, Gao Y: Clinical observation on 5-aminolevulinic acid-photodynamic and CO2 laser therapy in the treatment of condyloma acuminatum. China Foreign Treat 2011;14:52-54.
27.
Xiang G, Gong Y, Li B, et al: Clinical observation of photodynamic therapy combined with ultrapulse CO2 laser for condylomata acuminata. Chin J Dermatol Venereol 2008;22:741-742.
28.
Hu Y, Ni Q, Han Y, et al: Observation of the efficacy of topical 5-aminolevulinic acid photodynamic therapy combined with CO2 laser for the treatment of condyloma acuminatum. Chin J Dermatol Venereol 2009;23:581-582.
29.
Hu Y, Ren X, Hu E, et al: Observation of the efficacy of topical 5-aminolevulinic acid photodynamic therapy combined with CO2 laser for the treatment of condyloma acuminatum. Acta Acad Med Milit Ter 2010;32:999-1000.
30.
Liu M, Wu Y: Retrospective analysis of photodynamic therapy combined with CO2 laser for the treatment of condyloma acuminatum. Chin J Dermatol Venereol 2010;24:294.
31.
Yang R, Yang Y: Clinical effect of ALA-PDT on condyloma acuminatum. West China Med J 2009;24:1466-1467.
32.
Review Manager (RevMan) computer program, version 5.0. Copenhagen, Nordic Cochrane Centre, Cochrane Collaboration, 2007.
33.
Qi HP, Qu ZY, Duan SR, et al: IL-6-174 G/C and -572 C/G polymorphisms and risk of Alzheimer's disease. PLoS One 2012;7:e37858.
34.
Borenstein M, Hedges L, Higgins J, et al: Introduction to Meta-Analysis. Chichester, Wiley, 2009.
35.
Egger M, Smith GD, Schneider M, et al: Bias in Meta-Analysis detected by a sample, graphical test. BMJ 1997;315:629-634.
36.
Hengge UR: Papillomaviruserkrankungen. Hautarzt 2004;55:841-854.
37.
Braun-Falco O, Plewig G, Wolff HH, et al: Viral diseases; in: Dermatology. Berlin, Sprin-ger, 2000, pp 53-120.
38.
Kaceroska D, Pizinger K, Kumpova M, et al: Genital warts treated by photodynamic therapy. Skinmed 2007;6:295-297.
39.
Tchernev G: Sexually transmitted papillomavirus infections: epidemiology, pathogenesis, clinical morphology, important differential diagnostic aspects, and current diagnostic and treatment options. An Bras Dermatol 2009;84:377-389.
40.
Cao Y, Zhao J, Yang Z, et al: CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy. Clin Immunol 2010;136:21-29.
41.
Chen K, Chang BZ, Ju M, et al: Comparative study of photodynamic therapy vs. CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial. Br J Dermatol 2007;156:516-520.
42.
Xodo LE: Applications of the photodynamic therapy to cancer, water- and vector-borne diseases. Curr Med Chem 2012;19:780.
43.
Wang HW, Zhang LL, Wang XL, et al: Treatment of HPV infection-associated cervical condylomata acuminata with 5-aminolevulinic acid-mediated photodynamic therapy. Photochem Photobiol 2012;88:565-569.
44.
Wang XL, Wang HW, Wang HS, et al: Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol 2004;151:880-885.
45.
Johnson RP, Chung CW, Jeong YI, et al: Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy. Int J Nanomedicine 2012;7:2497-2512.
46.
Babilas P, Landthaler M, Szeimies RM: Photodynamic therapy in dermatology. Eur J Dermatol 2006;16:340-348.
47.
Calzavara-Pinton PG, Venturini M, Sala R: Photodynamic therapy: update 2006. Part 1. Photochemistry and photobiology. J Eur Acad Dermatol Venereol 2007;21:293-302.
48.
Giomi B, Pagnini F, Cappuccini A, et al: Immunological activity of photodynamic therapy for genital warts. Br J Dermatol 2011;164:448-451.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.